Dipeptidyl peptidase inhibitors for treating diabetes

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/513 (2006.01) A61K 31/44 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2622472

Pharmaceutical compositions comprising 2- [6- (3-Amino-piperidin-l-yl)-3- methyl-2, 4-dioxo-3, 4-dihydro-2H-pyrimidin-l-ylmethyl] -4-fluoro-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of manufacture comprising the pharmaceutical compositions as well as methods of using the pharmaceutical compositions. The compositions may be used for the treatment of diabetes.

L'invention concerne des compositions pharmaceutiques comprenant un 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile et des sels de celles-ci pharmaceutiquement acceptables ainsi que des trousses et des articles de production comprenant lesdites compositions pharmaceutiques et des méthodes d'utilisation de ces compositions pharmaceutiques. On peut utiliser lesdites compositions pour traiter le diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dipeptidyl peptidase inhibitors for treating diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dipeptidyl peptidase inhibitors for treating diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptidyl peptidase inhibitors for treating diabetes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2024983

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.